Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine.
- DOI
- 10.3389/fphar.2026.1911892
- Published
- 2026
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1911892,
title = {Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine.},
author = {Chen G and Yang H and Sun W and Shen J and Ma F and Qin J and Wang X and Liu Y and Chen N and Teng T and Sun S and Ji X},
year = {2026},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2026.1911892},
url = {https://doi.org/10.3389/fphar.2026.1911892}
}RIS
TY - JOUR TI - Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine. AU - Chen G AU - Yang H AU - Sun W AU - Shen J AU - Ma F AU - Qin J AU - Wang X AU - Liu Y AU - Chen N AU - Teng T AU - Sun S AU - Ji X PY - 2026 JO - Frontiers in pharmacology DO - 10.3389/fphar.2026.1911892 UR - https://doi.org/10.3389/fphar.2026.1911892 ER -
APA
G, C., H, Y., W, S., J, S., F, M., J, Q., X, W., Y, L., N, C., T, T., S, S., & X, J. (2026). Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1911892
Source records
- pubmed · retrieved 2026-09-25T11:20:05.671Z